Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ju Ma

Showing results (151-160 of 153) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 153 results.
Inflammatory Bowel Diseases|September 24, 2016
Effect of Long Noncoding RNA H19 Overexpression on Intestinal Barrier Function and Its Potential Role in the Pathogenesis of Ulcerative ColitisShan-Wen Chen, Peng-Yuan Wang, Yu-Cun Liu, et al.
Toxicology and Applied Pharmacology|September 21, 2007
Undecylprodigiosin selectively induces apoptosis in human breast carcinoma cells independent of p53Tsing-Fen Ho, Chieh-Ju Ma, Chien-Hsing Lu, et al.
American Journal of Cancer Research|March 9, 2022
Successful application of PD-1 knockdown CLL-1 CAR-T therapy in two AML patients with post-transplant relapse and failure of anti-CD38 CAR-T cell treatmentYun-Ju Ma, Hai-Ping Dai, Qing-Ya Cui, et al.
Pageof 16

Showing results (151-160 of 153) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 153 results.
Inflammatory Bowel Diseases|September 24, 2016
Effect of Long Noncoding RNA H19 Overexpression on Intestinal Barrier Function and Its Potential Role in the Pathogenesis of Ulcerative ColitisShan-Wen Chen, Peng-Yuan Wang, Yu-Cun Liu, et al.
Toxicology and Applied Pharmacology|September 21, 2007
Undecylprodigiosin selectively induces apoptosis in human breast carcinoma cells independent of p53Tsing-Fen Ho, Chieh-Ju Ma, Chien-Hsing Lu, et al.
American Journal of Cancer Research|March 9, 2022
Successful application of PD-1 knockdown CLL-1 CAR-T therapy in two AML patients with post-transplant relapse and failure of anti-CD38 CAR-T cell treatmentYun-Ju Ma, Hai-Ping Dai, Qing-Ya Cui, et al.
Pageof 16